Perritt Capital Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $144K | Sell |
10,000
-10,000
| -50% | -$144K | 0.07% | 171 |
|
|
2025
Q1 | $138K | Sell |
20,000
-20,000
| -50% | -$138K | 0.08% | 176 |
|
|
2024
Q4 | $212K | Hold |
40,000
| – | – | 0.11% | 156 |
|
|
2024
Q3 | $146K | Hold |
40,000
| – | – | 0.08% | 172 |
|
|
2024
Q2 | $109K | Hold |
40,000
| – | – | 0.06% | 187 |
|
|
2024
Q1 | $139K | Buy |
+40,000
| New | +$139K | 0.08% | 166 |
|